HEADER HYDROLASE/INHIBITOR 11-DEC-23 8VAU TITLE NICOTINAMIDE RIBOSIDE AND CD38: COVALENT INHIBITION AND LIVE-CELL TITLE 2 LABELING COMPND MOL_ID: 1; COMPND 2 MOLECULE: ADP-RIBOSYL CYCLASE/CYCLIC ADP-RIBOSE HYDROLASE 1; COMPND 3 CHAIN: A, B; COMPND 4 SYNONYM: 2'-PHOSPHO-ADP-RIBOSYL CYCLASE,2'-PHOSPHO-ADP-RIBOSYL COMPND 5 CYCLASE/2'-PHOSPHO-CYCLIC-ADP-RIBOSE TRANSFERASE,2'-PHOSPHO-CYCLIC- COMPND 6 ADP-RIBOSE TRANSFERASE,ADP-RIBOSYL CYCLASE 1,ADPRC 1,CYCLIC ADP- COMPND 7 RIBOSE HYDROLASE 1,CADPR HYDROLASE 1,T10; COMPND 8 EC: 3.2.2.6,2.4.99.20; COMPND 9 ENGINEERED: YES; COMPND 10 MUTATION: YES SOURCE MOL_ID: 1; SOURCE 2 ORGANISM_SCIENTIFIC: HOMO SAPIENS; SOURCE 3 ORGANISM_COMMON: HUMAN; SOURCE 4 ORGANISM_TAXID: 9606; SOURCE 5 GENE: CD38; SOURCE 6 EXPRESSION_SYSTEM: HOMO SAPIENS; SOURCE 7 EXPRESSION_SYSTEM_TAXID: 9606; SOURCE 8 EXPRESSION_SYSTEM_CELL_LINE: HEK293; SOURCE 9 EXPRESSION_SYSTEM_VECTOR_TYPE: PLASMID; SOURCE 10 EXPRESSION_SYSTEM_PLASMID: PFUSE KEYWDS NICOTINAMIDE RIBOSIDE, CD38, NUCLEOSIDE, INHIBITOR, HYDROLASE, KEYWDS 2 HYDROLASE-INHIBITOR COMPLEX EXPDTA X-RAY DIFFRACTION AUTHOR G.KAO,X.N.ZHANG,F.NASERTORABI,B.B.KATZ,Z.LI,Z.DAI,Z.ZHANG,L.ZHANG, AUTHOR 2 S.G.LOUIE,V.CHEREZOV,Y.ZHANG REVDAT 1 06-NOV-24 8VAU 0 JRNL AUTH G.KAO,X.N.ZHANG,F.NASERTORABI,B.B.KATZ,Z.LI,Z.DAI,Z.ZHANG, JRNL AUTH 2 L.ZHANG,S.G.LOUIE,V.CHEREZOV,Y.ZHANG JRNL TITL NICOTINAMIDE RIBOSIDE AND CD38: COVALENT INHIBITION AND JRNL TITL 2 LIVE-CELL LABELING JRNL REF JACS AU 2024 JRNL REFN ESSN 2691-3704 JRNL DOI 10.1021/JACSAU.4C00695 REMARK 2 REMARK 2 RESOLUTION. 2.10 ANGSTROMS. REMARK 3 REMARK 3 REFINEMENT. REMARK 3 PROGRAM : PHENIX (1.20.1_4487: ???) REMARK 3 AUTHORS : PAUL ADAMS,PAVEL AFONINE,VINCENT CHEN,IAN REMARK 3 : DAVIS,KRESHNA GOPAL,RALF GROSSE-KUNSTLEVE, REMARK 3 : LI-WEI HUNG,ROBERT IMMORMINO,TOM IOERGER, REMARK 3 : AIRLIE MCCOY,ERIK MCKEE,NIGEL MORIARTY, REMARK 3 : REETAL PAI,RANDY READ,JANE RICHARDSON, REMARK 3 : DAVID RICHARDSON,TOD ROMO,JIM SACCHETTINI, REMARK 3 : NICHOLAS SAUTER,JACOB SMITH,LAURENT REMARK 3 : STORONI,TOM TERWILLIGER,PETER ZWART REMARK 3 REMARK 3 REFINEMENT TARGET : ML REMARK 3 REMARK 3 DATA USED IN REFINEMENT. REMARK 3 RESOLUTION RANGE HIGH (ANGSTROMS) : 2.10 REMARK 3 RESOLUTION RANGE LOW (ANGSTROMS) : 34.71 REMARK 3 MIN(FOBS/SIGMA_FOBS) : 1.340 REMARK 3 COMPLETENESS FOR RANGE (%) : 97.1 REMARK 3 NUMBER OF REFLECTIONS : 33368 REMARK 3 REMARK 3 FIT TO DATA USED IN REFINEMENT. REMARK 3 R VALUE (WORKING + TEST SET) : 0.190 REMARK 3 R VALUE (WORKING SET) : 0.189 REMARK 3 FREE R VALUE : 0.219 REMARK 3 FREE R VALUE TEST SET SIZE (%) : 5.120 REMARK 3 FREE R VALUE TEST SET COUNT : 1710 REMARK 3 REMARK 3 FIT TO DATA USED IN REFINEMENT (IN BINS). REMARK 3 BIN RESOLUTION RANGE COMPL. NWORK NFREE RWORK RFREE REMARK 3 1 34.7100 - 4.8000 0.93 2632 124 0.1807 0.2060 REMARK 3 2 4.8000 - 3.8100 0.96 2653 148 0.1425 0.1664 REMARK 3 3 3.8100 - 3.3300 0.94 2564 120 0.1582 0.1909 REMARK 3 4 3.3300 - 3.0300 0.98 2646 143 0.1819 0.1991 REMARK 3 5 3.0300 - 2.8100 0.98 2655 158 0.1997 0.2102 REMARK 3 6 2.8100 - 2.6500 0.98 2677 156 0.2059 0.2421 REMARK 3 7 2.6500 - 2.5100 0.98 2616 140 0.2130 0.2737 REMARK 3 8 2.5100 - 2.4000 0.96 2608 133 0.2254 0.2677 REMARK 3 9 2.4000 - 2.3100 0.98 2638 140 0.2332 0.3048 REMARK 3 10 2.3100 - 2.2300 0.99 2676 139 0.2477 0.2822 REMARK 3 11 2.2300 - 2.1600 0.99 2669 162 0.2619 0.2756 REMARK 3 12 2.1600 - 2.1000 0.98 2624 147 0.2880 0.3438 REMARK 3 REMARK 3 BULK SOLVENT MODELLING. REMARK 3 METHOD USED : FLAT BULK SOLVENT MODEL REMARK 3 SOLVENT RADIUS : 1.10 REMARK 3 SHRINKAGE RADIUS : 0.90 REMARK 3 K_SOL : NULL REMARK 3 B_SOL : NULL REMARK 3 REMARK 3 ERROR ESTIMATES. REMARK 3 COORDINATE ERROR (MAXIMUM-LIKELIHOOD BASED) : 0.260 REMARK 3 PHASE ERROR (DEGREES, MAXIMUM-LIKELIHOOD BASED) : 25.950 REMARK 3 REMARK 3 B VALUES. REMARK 3 FROM WILSON PLOT (A**2) : 29.50 REMARK 3 MEAN B VALUE (OVERALL, A**2) : NULL REMARK 3 OVERALL ANISOTROPIC B VALUE. REMARK 3 B11 (A**2) : NULL REMARK 3 B22 (A**2) : NULL REMARK 3 B33 (A**2) : NULL REMARK 3 B12 (A**2) : NULL REMARK 3 B13 (A**2) : NULL REMARK 3 B23 (A**2) : NULL REMARK 3 REMARK 3 TWINNING INFORMATION. REMARK 3 FRACTION: NULL REMARK 3 OPERATOR: NULL REMARK 3 REMARK 3 DEVIATIONS FROM IDEAL VALUES. REMARK 3 RMSD COUNT REMARK 3 BOND : 0.002 4275 REMARK 3 ANGLE : 0.532 5821 REMARK 3 CHIRALITY : 0.041 639 REMARK 3 PLANARITY : 0.004 745 REMARK 3 DIHEDRAL : 12.860 1586 REMARK 3 REMARK 3 TLS DETAILS REMARK 3 NUMBER OF TLS GROUPS : 2 REMARK 3 TLS GROUP : 1 REMARK 3 SELECTION: ( CHAIN A AND ( RESID 44:292 OR RESID 401:402 ) ) REMARK 3 ORIGIN FOR THE GROUP (A): -13.516 -0.802 -6.427 REMARK 3 T TENSOR REMARK 3 T11: 0.2289 T22: 0.2425 REMARK 3 T33: 0.2458 T12: -0.0004 REMARK 3 T13: -0.0208 T23: -0.0079 REMARK 3 L TENSOR REMARK 3 L11: 0.5439 L22: 0.8590 REMARK 3 L33: 0.2710 L12: -0.1702 REMARK 3 L13: 0.1118 L23: -0.1782 REMARK 3 S TENSOR REMARK 3 S11: 0.0267 S12: -0.0218 S13: -0.0146 REMARK 3 S21: 0.0156 S22: -0.0081 S23: -0.0209 REMARK 3 S31: -0.0143 S32: 0.0044 S33: 0.0000 REMARK 3 TLS GROUP : 2 REMARK 3 SELECTION: ( CHAIN B AND ( RESID 44:293 OR RESID 401:402 ) ) REMARK 3 ORIGIN FOR THE GROUP (A): -9.196 -21.728 -39.748 REMARK 3 T TENSOR REMARK 3 T11: 0.2585 T22: 0.2638 REMARK 3 T33: 0.2397 T12: 0.0212 REMARK 3 T13: 0.0354 T23: -0.0021 REMARK 3 L TENSOR REMARK 3 L11: 0.2626 L22: 1.2756 REMARK 3 L33: 0.6842 L12: 0.0002 REMARK 3 L13: 0.0021 L23: -0.4143 REMARK 3 S TENSOR REMARK 3 S11: -0.0127 S12: -0.0098 S13: 0.0223 REMARK 3 S21: -0.0429 S22: -0.0426 S23: -0.1463 REMARK 3 S31: 0.0583 S32: 0.0391 S33: -0.0000 REMARK 3 REMARK 3 NCS DETAILS REMARK 3 NUMBER OF NCS GROUPS : NULL REMARK 3 REMARK 3 OTHER REFINEMENT REMARKS: NULL REMARK 4 REMARK 4 8VAU COMPLIES WITH FORMAT V. 3.30, 13-JUL-11 REMARK 100 REMARK 100 THIS ENTRY HAS BEEN PROCESSED BY RCSB ON 12-DEC-23. REMARK 100 THE DEPOSITION ID IS D_1000279585. REMARK 200 REMARK 200 EXPERIMENTAL DETAILS REMARK 200 EXPERIMENT TYPE : X-RAY DIFFRACTION REMARK 200 DATE OF DATA COLLECTION : 06-JUL-22 REMARK 200 TEMPERATURE (KELVIN) : 100 REMARK 200 PH : 6.8 - 7.3 REMARK 200 NUMBER OF CRYSTALS USED : 1 REMARK 200 REMARK 200 SYNCHROTRON (Y/N) : Y REMARK 200 RADIATION SOURCE : SSRL REMARK 200 BEAMLINE : BL12-1 REMARK 200 X-RAY GENERATOR MODEL : NULL REMARK 200 MONOCHROMATIC OR LAUE (M/L) : M REMARK 200 WAVELENGTH OR RANGE (A) : 0.979460 REMARK 200 MONOCHROMATOR : LIQUID NITROGEN-COOLED DOUBLE REMARK 200 -CRYSTAL SI(111) MONOCHROMATOR REMARK 200 WITH A 0.01% ENERGY BANDPASS REMARK 200 OPTICS : FLAT SIDE-DEFLECTING, RH-COATED REMARK 200 SI MIRROR. REMARK 200 REMARK 200 DETECTOR TYPE : PIXEL REMARK 200 DETECTOR MANUFACTURER : DECTRIS EIGER X 16M REMARK 200 INTENSITY-INTEGRATION SOFTWARE : XDS REMARK 200 DATA SCALING SOFTWARE : SCALA V. 3.3.22 REMARK 200 REMARK 200 NUMBER OF UNIQUE REFLECTIONS : 33411 REMARK 200 RESOLUTION RANGE HIGH (A) : 2.100 REMARK 200 RESOLUTION RANGE LOW (A) : 34.710 REMARK 200 REJECTION CRITERIA (SIGMA(I)) : NULL REMARK 200 REMARK 200 OVERALL. REMARK 200 COMPLETENESS FOR RANGE (%) : 97.6 REMARK 200 DATA REDUNDANCY : 4.400 REMARK 200 R MERGE (I) : 0.10200 REMARK 200 R SYM (I) : NULL REMARK 200 FOR THE DATA SET : 9.1000 REMARK 200 REMARK 200 IN THE HIGHEST RESOLUTION SHELL. REMARK 200 HIGHEST RESOLUTION SHELL, RANGE HIGH (A) : 2.10 REMARK 200 HIGHEST RESOLUTION SHELL, RANGE LOW (A) : 2.21 REMARK 200 COMPLETENESS FOR SHELL (%) : 99.2 REMARK 200 DATA REDUNDANCY IN SHELL : 4.40 REMARK 200 R MERGE FOR SHELL (I) : 0.68700 REMARK 200 R SYM FOR SHELL (I) : NULL REMARK 200 FOR SHELL : 2.500 REMARK 200 REMARK 200 DIFFRACTION PROTOCOL: SINGLE WAVELENGTH REMARK 200 METHOD USED TO DETERMINE THE STRUCTURE: MOLECULAR REPLACEMENT REMARK 200 SOFTWARE USED: PHASER V. 2.8.3 REMARK 200 STARTING MODEL: NULL REMARK 200 REMARK 200 REMARK: LARGE TWO DIMENTIONAL, THIN PLATELETS REMARK 280 REMARK 280 CRYSTAL REMARK 280 SOLVENT CONTENT, VS (%): 48.33 REMARK 280 MATTHEWS COEFFICIENT, VM (ANGSTROMS**3/DA): 2.38 REMARK 280 REMARK 280 CRYSTALLIZATION CONDITIONS: 100MM HEPES PH 7.0, 14-16% PEG 3350, REMARK 280 VAPOR DIFFUSION, HANGING DROP, TEMPERATURE 295K REMARK 290 REMARK 290 CRYSTALLOGRAPHIC SYMMETRY REMARK 290 SYMMETRY OPERATORS FOR SPACE GROUP: P 1 21 1 REMARK 290 REMARK 290 SYMOP SYMMETRY REMARK 290 NNNMMM OPERATOR REMARK 290 1555 X,Y,Z REMARK 290 2555 -X,Y+1/2,-Z REMARK 290 REMARK 290 WHERE NNN -> OPERATOR NUMBER REMARK 290 MMM -> TRANSLATION VECTOR REMARK 290 REMARK 290 CRYSTALLOGRAPHIC SYMMETRY TRANSFORMATIONS REMARK 290 THE FOLLOWING TRANSFORMATIONS OPERATE ON THE ATOM/HETATM REMARK 290 RECORDS IN THIS ENTRY TO PRODUCE CRYSTALLOGRAPHICALLY REMARK 290 RELATED MOLECULES. REMARK 290 SMTRY1 1 1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY2 1 0.000000 1.000000 0.000000 0.00000 REMARK 290 SMTRY3 1 0.000000 0.000000 1.000000 0.00000 REMARK 290 SMTRY1 2 -1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY2 2 0.000000 1.000000 0.000000 25.67550 REMARK 290 SMTRY3 2 0.000000 0.000000 -1.000000 0.00000 REMARK 290 REMARK 290 REMARK: NULL REMARK 300 REMARK 300 BIOMOLECULE: 1 REMARK 300 SEE REMARK 350 FOR THE AUTHOR PROVIDED AND/OR PROGRAM REMARK 300 GENERATED ASSEMBLY INFORMATION FOR THE STRUCTURE IN REMARK 300 THIS ENTRY. THE REMARK MAY ALSO PROVIDE INFORMATION ON REMARK 300 BURIED SURFACE AREA. REMARK 350 REMARK 350 COORDINATES FOR A COMPLETE MULTIMER REPRESENTING THE KNOWN REMARK 350 BIOLOGICALLY SIGNIFICANT OLIGOMERIZATION STATE OF THE REMARK 350 MOLECULE CAN BE GENERATED BY APPLYING BIOMT TRANSFORMATIONS REMARK 350 GIVEN BELOW. BOTH NON-CRYSTALLOGRAPHIC AND REMARK 350 CRYSTALLOGRAPHIC OPERATIONS ARE GIVEN. REMARK 350 REMARK 350 BIOMOLECULE: 1 REMARK 350 AUTHOR DETERMINED BIOLOGICAL UNIT: DIMERIC REMARK 350 APPLY THE FOLLOWING TO CHAINS: A, B REMARK 350 BIOMT1 1 1.000000 0.000000 0.000000 0.00000 REMARK 350 BIOMT2 1 0.000000 1.000000 0.000000 0.00000 REMARK 350 BIOMT3 1 0.000000 0.000000 1.000000 0.00000 REMARK 465 REMARK 465 MISSING RESIDUES REMARK 465 THE FOLLOWING RESIDUES WERE NOT LOCATED IN THE REMARK 465 EXPERIMENT. (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN REMARK 465 IDENTIFIER; SSSEQ=SEQUENCE NUMBER; I=INSERTION CODE.) REMARK 465 REMARK 465 M RES C SSSEQI REMARK 465 ASP A 293 REMARK 465 SER A 294 REMARK 465 SER A 295 REMARK 465 CYS A 296 REMARK 465 THR A 297 REMARK 465 SER A 298 REMARK 465 GLU A 299 REMARK 465 ILE A 300 REMARK 465 SER B 294 REMARK 465 SER B 295 REMARK 465 CYS B 296 REMARK 465 THR B 297 REMARK 465 SER B 298 REMARK 465 GLU B 299 REMARK 465 ILE B 300 REMARK 470 REMARK 470 MISSING ATOM REMARK 470 THE FOLLOWING RESIDUES HAVE MISSING ATOMS (M=MODEL NUMBER; REMARK 470 RES=RESIDUE NAME; C=CHAIN IDENTIFIER; SSEQ=SEQUENCE NUMBER; REMARK 470 I=INSERTION CODE): REMARK 470 M RES CSSEQI ATOMS REMARK 470 GLU A 292 CG CD OE1 OE2 REMARK 470 ARG B 280 CG CD NE CZ NH1 NH2 REMARK 470 LYS B 283 CG CD CE NZ REMARK 470 ASN B 290 CG OD1 ND2 REMARK 500 REMARK 500 GEOMETRY AND STEREOCHEMISTRY REMARK 500 SUBTOPIC: CLOSE CONTACTS IN SAME ASYMMETRIC UNIT REMARK 500 REMARK 500 THE FOLLOWING ATOMS ARE IN CLOSE CONTACT. REMARK 500 REMARK 500 ATM1 RES C SSEQI ATM2 RES C SSEQI DISTANCE REMARK 500 OE1 GLU A 162 O HOH A 501 2.12 REMARK 500 O SER A 213 O HOH A 502 2.19 REMARK 500 OD1 ASP B 81 O HOH B 501 2.19 REMARK 500 OE2 GLU A 226 O4 RIB A 402 2.19 REMARK 500 REMARK 500 REMARK: NULL REMARK 500 REMARK 500 GEOMETRY AND STEREOCHEMISTRY REMARK 500 SUBTOPIC: TORSION ANGLES REMARK 500 REMARK 500 TORSION ANGLES OUTSIDE THE EXPECTED RAMACHANDRAN REGIONS: REMARK 500 (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN IDENTIFIER; REMARK 500 SSEQ=SEQUENCE NUMBER; I=INSERTION CODE). REMARK 500 REMARK 500 STANDARD TABLE: REMARK 500 FORMAT:(10X,I3,1X,A3,1X,A1,I4,A1,4X,F7.2,3X,F7.2) REMARK 500 REMARK 500 EXPECTED VALUES: GJ KLEYWEGT AND TA JONES (1996). PHI/PSI- REMARK 500 CHOLOGY: RAMACHANDRAN REVISITED. STRUCTURE 4, 1395 - 1400 REMARK 500 REMARK 500 M RES CSSEQI PSI PHI REMARK 500 ARG A 127 -26.67 70.95 REMARK 500 ILE A 128 78.28 -106.79 REMARK 500 ASN A 182 56.24 -94.37 REMARK 500 ASP A 202 -116.17 63.36 REMARK 500 VAL A 225 -60.72 -124.73 REMARK 500 PRO A 291 44.74 -82.49 REMARK 500 ARG B 127 -25.52 70.47 REMARK 500 ILE B 128 73.80 -100.56 REMARK 500 CYS B 180 146.59 -173.41 REMARK 500 ASN B 182 57.30 -96.41 REMARK 500 ASP B 202 -109.38 60.80 REMARK 500 VAL B 225 -56.69 -128.21 REMARK 500 ARG B 247 75.77 69.38 REMARK 500 REMARK 500 REMARK: NULL DBREF 8VAU A 45 300 UNP P28907 CD38_HUMAN 45 300 DBREF 8VAU B 45 300 UNP P28907 CD38_HUMAN 45 300 SEQADV 8VAU SER A 44 UNP P28907 EXPRESSION TAG SEQADV 8VAU ASP A 100 UNP P28907 ASN 100 ENGINEERED MUTATION SEQADV 8VAU ALA A 164 UNP P28907 ASN 164 ENGINEERED MUTATION SEQADV 8VAU ASP A 209 UNP P28907 ASN 209 ENGINEERED MUTATION SEQADV 8VAU ASP A 219 UNP P28907 ASN 219 ENGINEERED MUTATION SEQADV 8VAU SER B 44 UNP P28907 EXPRESSION TAG SEQADV 8VAU ASP B 100 UNP P28907 ASN 100 ENGINEERED MUTATION SEQADV 8VAU ALA B 164 UNP P28907 ASN 164 ENGINEERED MUTATION SEQADV 8VAU ASP B 209 UNP P28907 ASN 209 ENGINEERED MUTATION SEQADV 8VAU ASP B 219 UNP P28907 ASN 219 ENGINEERED MUTATION SEQRES 1 A 257 SER ARG TRP ARG GLN GLN TRP SER GLY PRO GLY THR THR SEQRES 2 A 257 LYS ARG PHE PRO GLU THR VAL LEU ALA ARG CYS VAL LYS SEQRES 3 A 257 TYR THR GLU ILE HIS PRO GLU MET ARG HIS VAL ASP CYS SEQRES 4 A 257 GLN SER VAL TRP ASP ALA PHE LYS GLY ALA PHE ILE SER SEQRES 5 A 257 LYS HIS PRO CYS ASP ILE THR GLU GLU ASP TYR GLN PRO SEQRES 6 A 257 LEU MET LYS LEU GLY THR GLN THR VAL PRO CYS ASN LYS SEQRES 7 A 257 ILE LEU LEU TRP SER ARG ILE LYS ASP LEU ALA HIS GLN SEQRES 8 A 257 PHE THR GLN VAL GLN ARG ASP MET PHE THR LEU GLU ASP SEQRES 9 A 257 THR LEU LEU GLY TYR LEU ALA ASP ASP LEU THR TRP CYS SEQRES 10 A 257 GLY GLU PHE ALA THR SER LYS ILE ASN TYR GLN SER CYS SEQRES 11 A 257 PRO ASP TRP ARG LYS ASP CYS SER ASN ASN PRO VAL SER SEQRES 12 A 257 VAL PHE TRP LYS THR VAL SER ARG ARG PHE ALA GLU ALA SEQRES 13 A 257 ALA CYS ASP VAL VAL HIS VAL MET LEU ASP GLY SER ARG SEQRES 14 A 257 SER LYS ILE PHE ASP LYS ASP SER THR PHE GLY SER VAL SEQRES 15 A 257 GLU VAL HIS ASN LEU GLN PRO GLU LYS VAL GLN THR LEU SEQRES 16 A 257 GLU ALA TRP VAL ILE HIS GLY GLY ARG GLU ASP SER ARG SEQRES 17 A 257 ASP LEU CYS GLN ASP PRO THR ILE LYS GLU LEU GLU SER SEQRES 18 A 257 ILE ILE SER LYS ARG ASN ILE GLN PHE SER CYS LYS ASN SEQRES 19 A 257 ILE TYR ARG PRO ASP LYS PHE LEU GLN CYS VAL LYS ASN SEQRES 20 A 257 PRO GLU ASP SER SER CYS THR SER GLU ILE SEQRES 1 B 257 SER ARG TRP ARG GLN GLN TRP SER GLY PRO GLY THR THR SEQRES 2 B 257 LYS ARG PHE PRO GLU THR VAL LEU ALA ARG CYS VAL LYS SEQRES 3 B 257 TYR THR GLU ILE HIS PRO GLU MET ARG HIS VAL ASP CYS SEQRES 4 B 257 GLN SER VAL TRP ASP ALA PHE LYS GLY ALA PHE ILE SER SEQRES 5 B 257 LYS HIS PRO CYS ASP ILE THR GLU GLU ASP TYR GLN PRO SEQRES 6 B 257 LEU MET LYS LEU GLY THR GLN THR VAL PRO CYS ASN LYS SEQRES 7 B 257 ILE LEU LEU TRP SER ARG ILE LYS ASP LEU ALA HIS GLN SEQRES 8 B 257 PHE THR GLN VAL GLN ARG ASP MET PHE THR LEU GLU ASP SEQRES 9 B 257 THR LEU LEU GLY TYR LEU ALA ASP ASP LEU THR TRP CYS SEQRES 10 B 257 GLY GLU PHE ALA THR SER LYS ILE ASN TYR GLN SER CYS SEQRES 11 B 257 PRO ASP TRP ARG LYS ASP CYS SER ASN ASN PRO VAL SER SEQRES 12 B 257 VAL PHE TRP LYS THR VAL SER ARG ARG PHE ALA GLU ALA SEQRES 13 B 257 ALA CYS ASP VAL VAL HIS VAL MET LEU ASP GLY SER ARG SEQRES 14 B 257 SER LYS ILE PHE ASP LYS ASP SER THR PHE GLY SER VAL SEQRES 15 B 257 GLU VAL HIS ASN LEU GLN PRO GLU LYS VAL GLN THR LEU SEQRES 16 B 257 GLU ALA TRP VAL ILE HIS GLY GLY ARG GLU ASP SER ARG SEQRES 17 B 257 ASP LEU CYS GLN ASP PRO THR ILE LYS GLU LEU GLU SER SEQRES 18 B 257 ILE ILE SER LYS ARG ASN ILE GLN PHE SER CYS LYS ASN SEQRES 19 B 257 ILE TYR ARG PRO ASP LYS PHE LEU GLN CYS VAL LYS ASN SEQRES 20 B 257 PRO GLU ASP SER SER CYS THR SER GLU ILE HET NNR A 401 18 HET RIB A 402 9 HET NNR B 401 18 HET RIB B 402 9 HETNAM NNR NICOTINAMIDE RIBOSIDE HETNAM RIB ALPHA-D-RIBOFURANOSE HETSYN NNR 3-(AMINOCARBONYL)-1-BETA-D-RIBOFURANOSYLPYRIDINIUM HETSYN RIB ALPHA-D-RIBOSE; D-RIBOSE; RIBOSE FORMUL 3 NNR 2(C11 H15 N2 O5 1+) FORMUL 4 RIB 2(C5 H10 O5) FORMUL 7 HOH *300(H2 O) HELIX 1 AA1 ARG A 58 HIS A 74 1 17 HELIX 2 AA2 PRO A 75 ARG A 78 5 4 HELIX 3 AA3 ASP A 81 ILE A 94 1 14 HELIX 4 AA4 THR A 102 ASP A 105 5 4 HELIX 5 AA5 TYR A 106 GLY A 113 1 8 HELIX 6 AA6 ILE A 128 GLN A 139 1 12 HELIX 7 AA7 THR A 144 ASP A 147 5 4 HELIX 8 AA8 THR A 148 ASP A 155 1 8 HELIX 9 AA9 ASN A 183 ALA A 200 1 18 HELIX 10 AB1 SER A 220 VAL A 225 1 6 HELIX 11 AB2 ASP A 252 GLN A 255 5 4 HELIX 12 AB3 ASP A 256 ARG A 269 1 14 HELIX 13 AB4 ARG A 280 ASN A 290 1 11 HELIX 14 AB5 ARG B 58 HIS B 74 1 17 HELIX 15 AB6 PRO B 75 ARG B 78 5 4 HELIX 16 AB7 ASP B 81 ILE B 94 1 14 HELIX 17 AB8 THR B 102 ASP B 105 5 4 HELIX 18 AB9 TYR B 106 GLY B 113 1 8 HELIX 19 AC1 ILE B 128 GLN B 139 1 12 HELIX 20 AC2 THR B 144 ASP B 147 5 4 HELIX 21 AC3 THR B 148 ASP B 155 1 8 HELIX 22 AC4 ASN B 183 ALA B 200 1 18 HELIX 23 AC5 SER B 220 VAL B 225 1 6 HELIX 24 AC6 ASP B 252 GLN B 255 5 4 HELIX 25 AC7 ASP B 256 ARG B 269 1 14 HELIX 26 AC8 ARG B 280 ASN B 290 1 11 SHEET 1 AA1 2 GLY A 52 PRO A 53 0 SHEET 2 AA1 2 SER A 172 CYS A 173 -1 O CYS A 173 N GLY A 52 SHEET 1 AA2 4 LEU A 123 SER A 126 0 SHEET 2 AA2 4 ASP A 202 ASP A 209 1 O HIS A 205 N LEU A 124 SHEET 3 AA2 4 VAL A 235 ILE A 243 1 O TRP A 241 N VAL A 206 SHEET 4 AA2 4 GLN A 272 ILE A 278 1 O SER A 274 N ALA A 240 SHEET 1 AA3 2 GLY B 52 PRO B 53 0 SHEET 2 AA3 2 SER B 172 CYS B 173 -1 O CYS B 173 N GLY B 52 SHEET 1 AA4 4 LEU B 123 SER B 126 0 SHEET 2 AA4 4 ASP B 202 ASP B 209 1 O HIS B 205 N LEU B 124 SHEET 3 AA4 4 VAL B 235 ILE B 243 1 O ILE B 243 N LEU B 208 SHEET 4 AA4 4 GLN B 272 ILE B 278 1 O SER B 274 N ALA B 240 SSBOND 1 CYS A 67 CYS A 82 1555 1555 2.04 SSBOND 2 CYS A 99 CYS A 180 1555 1555 2.04 SSBOND 3 CYS A 119 CYS A 201 1555 1555 2.04 SSBOND 4 CYS A 160 CYS A 173 1555 1555 2.04 SSBOND 5 CYS A 254 CYS A 275 1555 1555 2.04 SSBOND 6 CYS B 67 CYS B 82 1555 1555 2.04 SSBOND 7 CYS B 99 CYS B 180 1555 1555 2.04 SSBOND 8 CYS B 119 CYS B 201 1555 1555 2.04 SSBOND 9 CYS B 160 CYS B 173 1555 1555 2.04 SSBOND 10 CYS B 254 CYS B 275 1555 1555 2.03 LINK OE2 GLU A 226 C1 RIB A 402 1555 1555 1.37 LINK OE2 GLU B 226 C1 RIB B 402 1555 1555 1.38 CRYST1 57.627 51.351 100.501 90.00 97.26 90.00 P 1 21 1 4 ORIGX1 1.000000 0.000000 0.000000 0.00000 ORIGX2 0.000000 1.000000 0.000000 0.00000 ORIGX3 0.000000 0.000000 1.000000 0.00000 SCALE1 0.017353 0.000000 0.002211 0.00000 SCALE2 0.000000 0.019474 0.000000 0.00000 SCALE3 0.000000 0.000000 0.010031 0.00000